Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe M Stanton

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|March 26, 2014
Inflammatory biomarkers for AMDChloe M Stanton, Alan F Wright
Advances in Experimental Medicine and Biology|December 21, 2011
The chromosome 10q26 susceptibility locus in age-related macular degenerationChloe M Stanton, Kevin J Chalmers, Alan F Wright
BMC Ophthalmology|March 29, 2022
Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case reportSu Ling Young, Chloe M Stanton, Benjamin J Livesey, et al.
Disease Models & Mechanisms|August 9, 2021
A mouse model of brittle cornea syndrome caused by mutation in Zfp469Chloe M Stanton, Amy S Findlay, Camilla Drake, et al.
The EMBO Journal|August 29, 2009
Editing independent effects of ADARs on the miRNA/siRNA pathwaysBret S E Heale, Liam P Keegan, Leeanne McGurk, et al.
Ophthalmic Genetics|November 20, 2018
Whole genome sequencing reveals novel mutations causing autosomal dominant inherited macular degenerationShyamanga Borooah, Chloe M Stanton, Joseph Marsh, et al.
Immunobiology|October 26, 2011
Genetic variation in complement regulators and susceptibility to age-related macular degenerationValentina Cipriani, Baljinder K Matharu, Jane C Khan, et al.
Progress in Retinal and Eye Research|December 13, 2022
10q26 - The enigma in age-related macular degenerationDavid A Merle, Merve Sen, Angela Armento, et al.
Scientific Reports|September 24, 2017
Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degenerationChloe M Stanton, Shyamanga Borooah, Camilla Drake, et al.
Investigative Ophthalmology & Visual Science|December 22, 2023
Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5Randa T H Li, Alejandro J Roman, Alexander Sumaroka, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|March 26, 2014
Inflammatory biomarkers for AMDChloe M Stanton, Alan F Wright
Advances in Experimental Medicine and Biology|December 21, 2011
The chromosome 10q26 susceptibility locus in age-related macular degenerationChloe M Stanton, Kevin J Chalmers, Alan F Wright
BMC Ophthalmology|March 29, 2022
Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case reportSu Ling Young, Chloe M Stanton, Benjamin J Livesey, et al.
Disease Models & Mechanisms|August 9, 2021
A mouse model of brittle cornea syndrome caused by mutation in Zfp469Chloe M Stanton, Amy S Findlay, Camilla Drake, et al.
The EMBO Journal|August 29, 2009
Editing independent effects of ADARs on the miRNA/siRNA pathwaysBret S E Heale, Liam P Keegan, Leeanne McGurk, et al.
Ophthalmic Genetics|November 20, 2018
Whole genome sequencing reveals novel mutations causing autosomal dominant inherited macular degenerationShyamanga Borooah, Chloe M Stanton, Joseph Marsh, et al.
Immunobiology|October 26, 2011
Genetic variation in complement regulators and susceptibility to age-related macular degenerationValentina Cipriani, Baljinder K Matharu, Jane C Khan, et al.
Progress in Retinal and Eye Research|December 13, 2022
10q26 - The enigma in age-related macular degenerationDavid A Merle, Merve Sen, Angela Armento, et al.
Scientific Reports|September 24, 2017
Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degenerationChloe M Stanton, Shyamanga Borooah, Camilla Drake, et al.
Investigative Ophthalmology & Visual Science|December 22, 2023
Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5Randa T H Li, Alejandro J Roman, Alexander Sumaroka, et al.
Pageof 2